Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective

被引:20
|
作者
Qu, Jiao [1 ]
Liu, Qianqian [1 ]
You, Guoquan [1 ]
Ye, Ling [2 ]
Jin, Yiguang [3 ]
Kong, Lingdong [1 ]
Guo, Wenjie [1 ]
Xu, Qiang [1 ,4 ]
Sun, Yang [1 ,4 ,5 ]
机构
[1] Nanjing Univ, Sch Life Sci, Dept Biotechnol & Pharmaceut Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Peoples R China
[2] Southern Med Univ, Sch Pharmaceut Sci, Biopharmaceut, Guangzhou, Peoples R China
[3] Beijing Inst Radiat Med, Dept Pharmaceut Sci, Beijing, Peoples R China
[4] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou, Jiangsu, Peoples R China
[5] Nanjing Univ, Chem & Biomed Innovat Ctr ChemBIC, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
andrographolide; drug delivery system; inflammatory diseases; pharmacodynamics; pharmacokinetics; NF-KAPPA-B; INDUCED PULMONARY-FIBROSIS; IN-VITRO; ORAL BIOAVAILABILITY; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; PANICULATA EXTRACT; COLORECTAL-CANCER; AIRWAY HYPERRESPONSIVENESS; INHIBITS PROLIFERATION;
D O I
10.1002/med.21873
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Andrographolide, a well-known natural lactone having a range of pharmacological actions in traditional Chinese medicine. It has long been used to cure a variety of ailments. In this review, we cover the pharmacokinetics and pharmacological activity of andrographolide which supports its further clinical application in cancers and inflammatory diseases. Growing evidence shows a good therapeutic effect in inflammatory diseases, including liver diseases, joint diseases, respiratory system diseases, nervous system diseases, heart diseases, inflammatory bowel diseases, and inflammatory skin diseases. As a result, the effects of andrographolide on immune cells and the processes that underpin them are discussed. The preclinical use of andrographolide to different organs in response to malignancies such as colorectal, liver, gastric, breast, prostate, lung, and oral cancers has also been reviewed. In addition, several clinical trials of andrographolide in inflammatory diseases and cancers have been summarized. This review highlights recent advances in ameliorating inflammatory diseases as well as cancers by andrographolide and its analogs, providing a new perspective for subsequent research of this traditional natural product.
引用
收藏
页码:1147 / 1178
页数:32
相关论文
共 50 条
  • [21] Nonsteroidal anti-inflammatory drugs in birds: pharmacokinetics, pharmacodynamics and toxicity
    Goessens, T.
    Antonissen, G.
    Croubels, S.
    De Backer, P.
    Devreese, M.
    VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 2016, 85 (02): : 55 - 62
  • [22] Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy
    Slaviero, KA
    Clarke, SJ
    Rivory, LP
    LANCET ONCOLOGY, 2003, 4 (04): : 224 - 232
  • [23] Propofol pharmacokinetics and pharmacodynamics-a perspective in minimally invasive extracorporeal circulation
    Condello, Ignazio
    Santarpino, Giuseppe
    Fiore, Flavio
    Di Bari, Nicola
    Speziale, Giuseppe
    Moscarelli, Marco
    Nasso, Giuseppe
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 33 (04) : 625 - 627
  • [24] Gynecological cancers in patients with inflammatory rheumatic diseases
    Schmalzing, M.
    Krockenberger, M.
    Honig, A.
    Tony, H. -P.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (01): : 63 - 67
  • [25] The Peritoneal Macrophages in Inflammatory Diseases and Abdominal Cancers
    Liu, Ting
    Liu, Fang
    Peng, Lei-Wen
    Chang, Li
    Jiang, Yong-Mei
    ONCOLOGY RESEARCH, 2018, 26 (05) : 817 - 826
  • [26] Obesity alters immunopathology in cancers and inflammatory diseases
    Zhang, Xiaofen
    Gao, Li
    Meng, Haiyang
    Zhang, Ailing
    Liang, Yan
    Lu, Jingli
    OBESITY REVIEWS, 2023, 24 (12)
  • [27] Inflammatory bowel diseases -: Standards and perspective
    Schölmerich, J
    CHIRURGISCHE GASTROENTEROLOGIE, 2002, 18 (04): : 300 - 301
  • [28] Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest
    Lees, P
    Landoni, MF
    Giraudel, J
    Toutain, PL
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (06) : 479 - 490
  • [29] Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
    E. G. Quetglas
    A. Armuzzi
    S. Wigge
    G. Fiorino
    L. Barnscheid
    M. Froelich
    Silvio Danese
    European Journal of Clinical Pharmacology, 2015, 71 : 773 - 799
  • [30] Pharmacokinetics, pharmacodynamics, and immunogenicity of biosimilar infliximab in pediatric patients with inflammatory bowel disease
    Dipasquale, V.
    Alibrandi, A.
    Pellegrino, S.
    Ramistella, V.
    Romano, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1618 - I1618